SeraCare posts $76,219 June income from operations

By Caroline Salls

Pittsburgh, July 26 - SeraCare Life Sciences, Inc. reported a $76,219 income from operations for June on $4.7 million in sales, according to its monthly operating report filed Wednesday with the U.S. Bankruptcy Court for the Southern District of California.

The figures compare to a $797,058 net operating loss for May on $4.81 million in sales.

The net income for June was $129,473, up from a $22,064 May net income.

Cash and cash equivalents on June 30 were $18.91 million.

SeraCare, an Oceanside, Calif., manufacturer and provider of biological products and services to diagnostic, therapeutic, drug discovery and research organizations, filed for bankruptcy on March 22. Its Chapter 11 case number is 06-00510.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.